Abstract

Raster scanning spectral domain optical coherence tomography (SD-OCT) enables realistic three-dimensional (3D) imaging of macular disease. This approach allows the clinician to investigate the diagnostic situation in detail before and during pharmacological or surgical intervention. This study demonstrates the clinical potential of SD-OCT in chorioretinal disease. Selected datasets are presented to visualize typical morphologic findings, which are identified in more than 2700 patients. Scans are presented as online assessable 3D-models. Clinically relevant structures are visualized in macular disease and highlight the importance of precise imaging, which clearly is a clinical necessity to plan and indicate modern therapeutic strategies for our patients.

© 2009 Optical Society of America

Full Article  |  PDF Article
Related Articles
S cone pathway sensitivity in eyes with high risk and low risk drusen characteristics

Janet S. Sunness, Robert W. Massof, Neil M. Bressler, and Susan B. Bressler
Appl. Opt. 28(6) 1158-1164 (1989)

Multiply scattered light tomography and confocal imaging: detecting neovascularization in age-related macular degeneration

A.E. Elsner, M. Miura, S.A. Burns, E. Beausencourt, C. Kunze, L.M. Kelley, J.P. Walker, G.L. Wing, P.A. Raskauskas, D.C. Fletcher, Q. Zhou, and A.W. Dreher
Opt. Express 7(2) 95-106 (2000)

Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations

Artur V. Cideciyan, Malgorzata Swider, Tomas S. Aleman, Marisa I. Roman, Alexander Sumaroka, Sharon B. Schwartz, Edwin M. Stone, and Samuel G. Jacobson
J. Opt. Soc. Am. A 24(5) 1457-1467 (2007)

References

  • View by:
  • |
  • |
  • |

  1. M. R. Hee, J. A. Izatt, E. A. Swanson, D. Huang, J. S. Schuman, C. P. Lin, C. A. Puliafito, and J. G. Fujimoto, “Optical coherence tomography of the human retina,” Arch Ophthalmol 113, 325–332 (1995).
    [PubMed]
  2. C. A. Puliafito, M. R. Hee, C. P. Lin, E. Reichel, J. S. Schuman, J. S. Duker, J. A. Izatt, E. A. Swanson, and J. G. Fujimoto, “Imaging of macular diseases with optical coherence tomography,” Ophthalmology 102, 217–229 (1995).
    [PubMed]
  3. D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
    [Crossref] [PubMed]
  4. M. R. Hee, C. A. Puliafito, C. Wong, J. S. Duker, E. Reichel, B. Rutledge, J. S. Schuman, E. A. Swanson, and J. G. Fujimoto, “Quantitative assessment of macular edema with optical coherence tomography,” Arch Ophthalmol 113, 1019–1029 (1995).
    [PubMed]
  5. M. Shahidi, Y. Ogura, N. P. Blair, M. M. Rusin, and R. Zeimer, “Retinal thickness analysis for quantitative assessment of diabetic macular edema,” Arch Ophthalmol 109, 1115–1119 (1991).
    [PubMed]
  6. “Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group,” Ophthalmology98, 807–822 (1991).
    [PubMed]
  7. C. S. Yang, C. Y. Cheng, F. L. Lee, W. M. Hsu, and J. H. Liu, “Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography,” Acta Ophthalmol Scand 79, 266–270 (2001).
    [Crossref] [PubMed]
  8. A. Giovannini, G. Amato, and C. Mariotti, “The macular thickness and volume in glaucoma: an analysis in normal and glaucomatous eyes using OCT,” Acta Ophthalmol Scand Suppl 236, 34–36 (2002).
    [Crossref] [PubMed]
  9. A. Polito, S. M. Shah, J. A. Haller, I. Zimmer-Galler, R. Zeimer, P. A. Campochiaro, and S. Vitale, “Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease,” Am J Ophthalmol 134, 240–251 (2002).
    [Crossref] [PubMed]
  10. N. Ferrara, H. P. Gerber, and J. LeCouter, “The biology of VEGF and its receptors,” Nat Med 9, 669–676 (2003).
    [Crossref] [PubMed]
  11. D. M. Brown, P. K. Kaiser, M. Michels, G. Soubrane, J. S. Heier, R. Y. Kim, J. P. Sy, and S. Schneider, “Ranibizumab versus verteporfin for neovascular age-related macular degeneration,” N Engl J Med 355, 1432–1444 (2006).
    [Crossref] [PubMed]
  12. P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, and R. Y. Kim, “Ranibizumab for neovascular age-related macular degeneration,” N Engl J Med 355, 1419–1431 (2006).
    [Crossref] [PubMed]
  13. U. M. Schmidt-Erfurth and C. Pruente, “Management of neovascular age-related macular degeneration,” Prog Retin Eye Res 26, 437–451 (2007).
    [Crossref] [PubMed]
  14. U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
    [Crossref] [PubMed]
  15. A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
    [Crossref] [PubMed]
  16. S. R. Sadda, Z. Wu, A. C. Walsh, L. Richine, J. Dougall, R. Cortez, and L. D. LaBree, “Errors in retinal thickness measurements obtained by optical coherence tomography,” Ophthalmology 113, 285–293 (2006).
    [Crossref] [PubMed]
  17. P. J. Patel, F. K. Chen, F. Ikeji, W. Xing, C. Bunce, L. Da Cruz, and A. Tufail, “Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration,” Invest Ophthalmol Vis Sci 49, 1084–1088 (2008).
    [Crossref] [PubMed]
  18. G. M. Somfai, H. M. Salinas, C. A. Puliafito, and D. C. Fernandez, “Evaluation of potential image acquisition pitfalls during optical coherence tomography and their influence on retinal image segmentation,” J Biomed Opt 12, 041209 (2007).
    [Crossref] [PubMed]
  19. P. J. Patel, F. K. Chen, L. da Cruz, and A. Tufail, “Segmentation Error in Stratus Optical Coherence Tomography for Neovascular Age-related Macular Degeneration,” Invest Ophthalmol Vis Sci. 50, 399–404 (2008).
    [Crossref] [PubMed]
  20. U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
    [Crossref] [PubMed]
  21. T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
    [Crossref]
  22. Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
    [Crossref] [PubMed]
  23. C. G. Pieroni, A. J. Witkin, T. H. Ko, J. G. Fujimoto, A. Chan, J. S. Schuman, H. Ishikawa, E. Reichel, and J. S. Duker, “Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration,” Br J Ophthalmol 90, 191–197 (2006).
    [Crossref] [PubMed]
  24. V. J. Srinivasan, M. Wojtkowski, A. J. Witkin, J. S. Duker, T. H. Ko, M. Carvalho, J. S. Schuman, A. Kowalczyk, and J. G. Fujimoto, “High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 113, 2054 e2051–2014 (2006).
    [Crossref]
  25. M. E. van Velthoven, D. J. Faber, F. D. Verbraak, T. G. van Leeuwen, and M. D. de Smet, “Recent developments in optical coherence tomography for imaging the retina,” Prog Retin Eye Res 26, 57–77 (2007).
    [Crossref]
  26. M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
    [Crossref] [PubMed]
  27. W. Drexler and J. G. Fujimoto, “State-of-the-art retinal optical coherence tomography,” Prog Retin Eye Res 27, 45–88 (2008).
    [Crossref]
  28. V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
    [Crossref] [PubMed]
  29. M. Wojtkowski, V. Srinivasan, J. G. Fujimoto, T. Ko, J. S. Schuman, A. Kowalczyk, and J. S. Duker, “Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 112, 1734–1746 (2005).
    [Crossref] [PubMed]
  30. C. Ahlers, C. Simader, W. Geitzenauer, G. Stock, P. Stetson, S. Dastmalchi, and U. Schmidt-Erfurth, “Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography,” Br J Ophthalmol 92, 197–203 (2008).
    [Crossref]
  31. P Sen, A Bhargava, L Vijaya, and R George, “Prevalence of idiopathic macular hole in adult rural and urban south Indian population,” Clin Experiment Ophthalmol. 36, 257–260 (2008).
    [Crossref] [PubMed]
  32. C. Ahlers, I. Golbaz, G. Stock, A. Fous, S. Kolar, C. Pruente, and U. Schmidt-Erfurth, “Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration,” Ophthalmology 115, e39–46 (2008).
    [Crossref] [PubMed]
  33. J. Michalewski, Z. Michalewska, S. Cisiecki, and J. Nawrocki, “Morphologically functional correlations of macular pathology connected with epiretinal membrane formation in spectral optical coherence tomography (SOCT),” Graefes Arch Clin Exp Ophthalmol 245, 1623–1631 (2007).
    [Crossref] [PubMed]
  34. N. Villate, J. E. Lee, A. Venkatraman, and W. E. Smiddy, “Photoreceptor layer features in eyes with closed macular holes: optical coherence tomography findings and correlation with visual outcomes,” Am J Ophthalmol 139, 280–289 (2005).
    [Crossref] [PubMed]
  35. UE Wolf-Schnurrbusch, V Enzmann, CK Brinkmann, and S Wolf “Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination” Invest Ophthalmol Vis Sci. 49, 3095–3099 (2008). Epub 2008 Mar 31.
    [Crossref] [PubMed]
  36. M Fleckenstein, P Charbel Issa, HM Helb, S Schmitz-Valckenberg, RP Finger, HP Scholl, KU Loeffler, and FG Holz. “High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration” Invest Ophthalmol Vis Sci. 49, 4137–4144 (2008). Epub 2008 May 16.
    [Crossref] [PubMed]

2008 (8)

P. J. Patel, F. K. Chen, F. Ikeji, W. Xing, C. Bunce, L. Da Cruz, and A. Tufail, “Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration,” Invest Ophthalmol Vis Sci 49, 1084–1088 (2008).
[Crossref] [PubMed]

P. J. Patel, F. K. Chen, L. da Cruz, and A. Tufail, “Segmentation Error in Stratus Optical Coherence Tomography for Neovascular Age-related Macular Degeneration,” Invest Ophthalmol Vis Sci. 50, 399–404 (2008).
[Crossref] [PubMed]

W. Drexler and J. G. Fujimoto, “State-of-the-art retinal optical coherence tomography,” Prog Retin Eye Res 27, 45–88 (2008).
[Crossref]

C. Ahlers, C. Simader, W. Geitzenauer, G. Stock, P. Stetson, S. Dastmalchi, and U. Schmidt-Erfurth, “Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography,” Br J Ophthalmol 92, 197–203 (2008).
[Crossref]

P Sen, A Bhargava, L Vijaya, and R George, “Prevalence of idiopathic macular hole in adult rural and urban south Indian population,” Clin Experiment Ophthalmol. 36, 257–260 (2008).
[Crossref] [PubMed]

C. Ahlers, I. Golbaz, G. Stock, A. Fous, S. Kolar, C. Pruente, and U. Schmidt-Erfurth, “Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration,” Ophthalmology 115, e39–46 (2008).
[Crossref] [PubMed]

UE Wolf-Schnurrbusch, V Enzmann, CK Brinkmann, and S Wolf “Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination” Invest Ophthalmol Vis Sci. 49, 3095–3099 (2008). Epub 2008 Mar 31.
[Crossref] [PubMed]

M Fleckenstein, P Charbel Issa, HM Helb, S Schmitz-Valckenberg, RP Finger, HP Scholl, KU Loeffler, and FG Holz. “High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration” Invest Ophthalmol Vis Sci. 49, 4137–4144 (2008). Epub 2008 May 16.
[Crossref] [PubMed]

2007 (8)

J. Michalewski, Z. Michalewska, S. Cisiecki, and J. Nawrocki, “Morphologically functional correlations of macular pathology connected with epiretinal membrane formation in spectral optical coherence tomography (SOCT),” Graefes Arch Clin Exp Ophthalmol 245, 1623–1631 (2007).
[Crossref] [PubMed]

M. E. van Velthoven, D. J. Faber, F. D. Verbraak, T. G. van Leeuwen, and M. D. de Smet, “Recent developments in optical coherence tomography for imaging the retina,” Prog Retin Eye Res 26, 57–77 (2007).
[Crossref]

M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
[Crossref] [PubMed]

Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
[Crossref] [PubMed]

G. M. Somfai, H. M. Salinas, C. A. Puliafito, and D. C. Fernandez, “Evaluation of potential image acquisition pitfalls during optical coherence tomography and their influence on retinal image segmentation,” J Biomed Opt 12, 041209 (2007).
[Crossref] [PubMed]

U. M. Schmidt-Erfurth and C. Pruente, “Management of neovascular age-related macular degeneration,” Prog Retin Eye Res 26, 437–451 (2007).
[Crossref] [PubMed]

U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
[Crossref] [PubMed]

A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
[Crossref] [PubMed]

2006 (6)

S. R. Sadda, Z. Wu, A. C. Walsh, L. Richine, J. Dougall, R. Cortez, and L. D. LaBree, “Errors in retinal thickness measurements obtained by optical coherence tomography,” Ophthalmology 113, 285–293 (2006).
[Crossref] [PubMed]

D. M. Brown, P. K. Kaiser, M. Michels, G. Soubrane, J. S. Heier, R. Y. Kim, J. P. Sy, and S. Schneider, “Ranibizumab versus verteporfin for neovascular age-related macular degeneration,” N Engl J Med 355, 1432–1444 (2006).
[Crossref] [PubMed]

P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, and R. Y. Kim, “Ranibizumab for neovascular age-related macular degeneration,” N Engl J Med 355, 1419–1431 (2006).
[Crossref] [PubMed]

C. G. Pieroni, A. J. Witkin, T. H. Ko, J. G. Fujimoto, A. Chan, J. S. Schuman, H. Ishikawa, E. Reichel, and J. S. Duker, “Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration,” Br J Ophthalmol 90, 191–197 (2006).
[Crossref] [PubMed]

V. J. Srinivasan, M. Wojtkowski, A. J. Witkin, J. S. Duker, T. H. Ko, M. Carvalho, J. S. Schuman, A. Kowalczyk, and J. G. Fujimoto, “High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 113, 2054 e2051–2014 (2006).
[Crossref]

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

2005 (4)

M. Wojtkowski, V. Srinivasan, J. G. Fujimoto, T. Ko, J. S. Schuman, A. Kowalczyk, and J. S. Duker, “Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 112, 1734–1746 (2005).
[Crossref] [PubMed]

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
[Crossref]

N. Villate, J. E. Lee, A. Venkatraman, and W. E. Smiddy, “Photoreceptor layer features in eyes with closed macular holes: optical coherence tomography findings and correlation with visual outcomes,” Am J Ophthalmol 139, 280–289 (2005).
[Crossref] [PubMed]

2003 (1)

N. Ferrara, H. P. Gerber, and J. LeCouter, “The biology of VEGF and its receptors,” Nat Med 9, 669–676 (2003).
[Crossref] [PubMed]

2002 (2)

A. Giovannini, G. Amato, and C. Mariotti, “The macular thickness and volume in glaucoma: an analysis in normal and glaucomatous eyes using OCT,” Acta Ophthalmol Scand Suppl 236, 34–36 (2002).
[Crossref] [PubMed]

A. Polito, S. M. Shah, J. A. Haller, I. Zimmer-Galler, R. Zeimer, P. A. Campochiaro, and S. Vitale, “Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease,” Am J Ophthalmol 134, 240–251 (2002).
[Crossref] [PubMed]

2001 (1)

C. S. Yang, C. Y. Cheng, F. L. Lee, W. M. Hsu, and J. H. Liu, “Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography,” Acta Ophthalmol Scand 79, 266–270 (2001).
[Crossref] [PubMed]

1995 (3)

M. R. Hee, J. A. Izatt, E. A. Swanson, D. Huang, J. S. Schuman, C. P. Lin, C. A. Puliafito, and J. G. Fujimoto, “Optical coherence tomography of the human retina,” Arch Ophthalmol 113, 325–332 (1995).
[PubMed]

C. A. Puliafito, M. R. Hee, C. P. Lin, E. Reichel, J. S. Schuman, J. S. Duker, J. A. Izatt, E. A. Swanson, and J. G. Fujimoto, “Imaging of macular diseases with optical coherence tomography,” Ophthalmology 102, 217–229 (1995).
[PubMed]

M. R. Hee, C. A. Puliafito, C. Wong, J. S. Duker, E. Reichel, B. Rutledge, J. S. Schuman, E. A. Swanson, and J. G. Fujimoto, “Quantitative assessment of macular edema with optical coherence tomography,” Arch Ophthalmol 113, 1019–1029 (1995).
[PubMed]

1991 (2)

M. Shahidi, Y. Ogura, N. P. Blair, M. M. Rusin, and R. Zeimer, “Retinal thickness analysis for quantitative assessment of diabetic macular edema,” Arch Ophthalmol 109, 1115–1119 (1991).
[PubMed]

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
[Crossref] [PubMed]

Ahlers, C.

C. Ahlers, C. Simader, W. Geitzenauer, G. Stock, P. Stetson, S. Dastmalchi, and U. Schmidt-Erfurth, “Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography,” Br J Ophthalmol 92, 197–203 (2008).
[Crossref]

C. Ahlers, I. Golbaz, G. Stock, A. Fous, S. Kolar, C. Pruente, and U. Schmidt-Erfurth, “Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration,” Ophthalmology 115, e39–46 (2008).
[Crossref] [PubMed]

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

Amato, G.

A. Giovannini, G. Amato, and C. Mariotti, “The macular thickness and volume in glaucoma: an analysis in normal and glaucomatous eyes using OCT,” Acta Ophthalmol Scand Suppl 236, 34–36 (2002).
[Crossref] [PubMed]

Augustin, A.

U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
[Crossref] [PubMed]

Aylward, W. G.

U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
[Crossref] [PubMed]

Bandello, F.

U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
[Crossref] [PubMed]

Bhargava, A

P Sen, A Bhargava, L Vijaya, and R George, “Prevalence of idiopathic macular hole in adult rural and urban south Indian population,” Clin Experiment Ophthalmol. 36, 257–260 (2008).
[Crossref] [PubMed]

Bilonick, R. A.

M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
[Crossref] [PubMed]

Blair, N. P.

M. Shahidi, Y. Ogura, N. P. Blair, M. M. Rusin, and R. Zeimer, “Retinal thickness analysis for quantitative assessment of diabetic macular edema,” Arch Ophthalmol 109, 1115–1119 (1991).
[PubMed]

Boyer, D. S.

P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, and R. Y. Kim, “Ranibizumab for neovascular age-related macular degeneration,” N Engl J Med 355, 1419–1431 (2006).
[Crossref] [PubMed]

Brinkmann, CK

UE Wolf-Schnurrbusch, V Enzmann, CK Brinkmann, and S Wolf “Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination” Invest Ophthalmol Vis Sci. 49, 3095–3099 (2008). Epub 2008 Mar 31.
[Crossref] [PubMed]

Brown, D. M.

P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, and R. Y. Kim, “Ranibizumab for neovascular age-related macular degeneration,” N Engl J Med 355, 1419–1431 (2006).
[Crossref] [PubMed]

D. M. Brown, P. K. Kaiser, M. Michels, G. Soubrane, J. S. Heier, R. Y. Kim, J. P. Sy, and S. Schneider, “Ranibizumab versus verteporfin for neovascular age-related macular degeneration,” N Engl J Med 355, 1432–1444 (2006).
[Crossref] [PubMed]

Bunce, C.

P. J. Patel, F. K. Chen, F. Ikeji, W. Xing, C. Bunce, L. Da Cruz, and A. Tufail, “Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration,” Invest Ophthalmol Vis Sci 49, 1084–1088 (2008).
[Crossref] [PubMed]

Bursell, S. E.

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

Campochiaro, P. A.

A. Polito, S. M. Shah, J. A. Haller, I. Zimmer-Galler, R. Zeimer, P. A. Campochiaro, and S. Vitale, “Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease,” Am J Ophthalmol 134, 240–251 (2002).
[Crossref] [PubMed]

Carvalho, M.

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

V. J. Srinivasan, M. Wojtkowski, A. J. Witkin, J. S. Duker, T. H. Ko, M. Carvalho, J. S. Schuman, A. Kowalczyk, and J. G. Fujimoto, “High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 113, 2054 e2051–2014 (2006).
[Crossref]

Chan, A.

C. G. Pieroni, A. J. Witkin, T. H. Ko, J. G. Fujimoto, A. Chan, J. S. Schuman, H. Ishikawa, E. Reichel, and J. S. Duker, “Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration,” Br J Ophthalmol 90, 191–197 (2006).
[Crossref] [PubMed]

Chang, W.

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
[Crossref] [PubMed]

Charbel Issa, P

M Fleckenstein, P Charbel Issa, HM Helb, S Schmitz-Valckenberg, RP Finger, HP Scholl, KU Loeffler, and FG Holz. “High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration” Invest Ophthalmol Vis Sci. 49, 4137–4144 (2008). Epub 2008 May 16.
[Crossref] [PubMed]

Chen, F. K.

P. J. Patel, F. K. Chen, F. Ikeji, W. Xing, C. Bunce, L. Da Cruz, and A. Tufail, “Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration,” Invest Ophthalmol Vis Sci 49, 1084–1088 (2008).
[Crossref] [PubMed]

P. J. Patel, F. K. Chen, L. da Cruz, and A. Tufail, “Segmentation Error in Stratus Optical Coherence Tomography for Neovascular Age-related Macular Degeneration,” Invest Ophthalmol Vis Sci. 50, 399–404 (2008).
[Crossref] [PubMed]

Cheng, C. Y.

C. S. Yang, C. Y. Cheng, F. L. Lee, W. M. Hsu, and J. H. Liu, “Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography,” Acta Ophthalmol Scand 79, 266–270 (2001).
[Crossref] [PubMed]

Chung, C. Y.

P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, and R. Y. Kim, “Ranibizumab for neovascular age-related macular degeneration,” N Engl J Med 355, 1419–1431 (2006).
[Crossref] [PubMed]

Cisiecki, S.

J. Michalewski, Z. Michalewska, S. Cisiecki, and J. Nawrocki, “Morphologically functional correlations of macular pathology connected with epiretinal membrane formation in spectral optical coherence tomography (SOCT),” Graefes Arch Clin Exp Ophthalmol 245, 1623–1631 (2007).
[Crossref] [PubMed]

Clermont, A.

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

Corcostegui, B.

U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
[Crossref] [PubMed]

Cortez, R.

S. R. Sadda, Z. Wu, A. C. Walsh, L. Richine, J. Dougall, R. Cortez, and L. D. LaBree, “Errors in retinal thickness measurements obtained by optical coherence tomography,” Ophthalmology 113, 285–293 (2006).
[Crossref] [PubMed]

Cunha-Vaz, J.

U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
[Crossref] [PubMed]

Da Cruz, L.

P. J. Patel, F. K. Chen, F. Ikeji, W. Xing, C. Bunce, L. Da Cruz, and A. Tufail, “Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration,” Invest Ophthalmol Vis Sci 49, 1084–1088 (2008).
[Crossref] [PubMed]

P. J. Patel, F. K. Chen, L. da Cruz, and A. Tufail, “Segmentation Error in Stratus Optical Coherence Tomography for Neovascular Age-related Macular Degeneration,” Invest Ophthalmol Vis Sci. 50, 399–404 (2008).
[Crossref] [PubMed]

Dastmalchi, S.

C. Ahlers, C. Simader, W. Geitzenauer, G. Stock, P. Stetson, S. Dastmalchi, and U. Schmidt-Erfurth, “Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography,” Br J Ophthalmol 92, 197–203 (2008).
[Crossref]

Davis, J. L.

A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
[Crossref] [PubMed]

de Smet, M. D.

M. E. van Velthoven, D. J. Faber, F. D. Verbraak, T. G. van Leeuwen, and M. D. de Smet, “Recent developments in optical coherence tomography for imaging the retina,” Prog Retin Eye Res 26, 57–77 (2007).
[Crossref]

Dougall, J.

S. R. Sadda, Z. Wu, A. C. Walsh, L. Richine, J. Dougall, R. Cortez, and L. D. LaBree, “Errors in retinal thickness measurements obtained by optical coherence tomography,” Ophthalmology 113, 285–293 (2006).
[Crossref] [PubMed]

Drexler, W.

W. Drexler and J. G. Fujimoto, “State-of-the-art retinal optical coherence tomography,” Prog Retin Eye Res 27, 45–88 (2008).
[Crossref]

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
[Crossref]

Dubovy, S. R.

A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
[Crossref] [PubMed]

Duker, J. S.

M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
[Crossref] [PubMed]

V. J. Srinivasan, M. Wojtkowski, A. J. Witkin, J. S. Duker, T. H. Ko, M. Carvalho, J. S. Schuman, A. Kowalczyk, and J. G. Fujimoto, “High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 113, 2054 e2051–2014 (2006).
[Crossref]

C. G. Pieroni, A. J. Witkin, T. H. Ko, J. G. Fujimoto, A. Chan, J. S. Schuman, H. Ishikawa, E. Reichel, and J. S. Duker, “Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration,” Br J Ophthalmol 90, 191–197 (2006).
[Crossref] [PubMed]

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

M. Wojtkowski, V. Srinivasan, J. G. Fujimoto, T. Ko, J. S. Schuman, A. Kowalczyk, and J. S. Duker, “Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 112, 1734–1746 (2005).
[Crossref] [PubMed]

T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
[Crossref]

M. R. Hee, C. A. Puliafito, C. Wong, J. S. Duker, E. Reichel, B. Rutledge, J. S. Schuman, E. A. Swanson, and J. G. Fujimoto, “Quantitative assessment of macular edema with optical coherence tomography,” Arch Ophthalmol 113, 1019–1029 (1995).
[PubMed]

C. A. Puliafito, M. R. Hee, C. P. Lin, E. Reichel, J. S. Schuman, J. S. Duker, J. A. Izatt, E. A. Swanson, and J. G. Fujimoto, “Imaging of macular diseases with optical coherence tomography,” Ophthalmology 102, 217–229 (1995).
[PubMed]

Enzmann, V

UE Wolf-Schnurrbusch, V Enzmann, CK Brinkmann, and S Wolf “Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination” Invest Ophthalmol Vis Sci. 49, 3095–3099 (2008). Epub 2008 Mar 31.
[Crossref] [PubMed]

Esquiabro, M.

A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
[Crossref] [PubMed]

Faber, D. J.

M. E. van Velthoven, D. J. Faber, F. D. Verbraak, T. G. van Leeuwen, and M. D. de Smet, “Recent developments in optical coherence tomography for imaging the retina,” Prog Retin Eye Res 26, 57–77 (2007).
[Crossref]

Fercher, A. F.

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

Fernandez, D. C.

G. M. Somfai, H. M. Salinas, C. A. Puliafito, and D. C. Fernandez, “Evaluation of potential image acquisition pitfalls during optical coherence tomography and their influence on retinal image segmentation,” J Biomed Opt 12, 041209 (2007).
[Crossref] [PubMed]

Ferrara, N.

N. Ferrara, H. P. Gerber, and J. LeCouter, “The biology of VEGF and its receptors,” Nat Med 9, 669–676 (2003).
[Crossref] [PubMed]

Feuer, W. J.

A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
[Crossref] [PubMed]

Finger, RP

M Fleckenstein, P Charbel Issa, HM Helb, S Schmitz-Valckenberg, RP Finger, HP Scholl, KU Loeffler, and FG Holz. “High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration” Invest Ophthalmol Vis Sci. 49, 4137–4144 (2008). Epub 2008 May 16.
[Crossref] [PubMed]

Fleckenstein, M

M Fleckenstein, P Charbel Issa, HM Helb, S Schmitz-Valckenberg, RP Finger, HP Scholl, KU Loeffler, and FG Holz. “High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration” Invest Ophthalmol Vis Sci. 49, 4137–4144 (2008). Epub 2008 May 16.
[Crossref] [PubMed]

Flotte, T.

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
[Crossref] [PubMed]

Flynn, Jr., H. W.

A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
[Crossref] [PubMed]

Fous, A.

C. Ahlers, I. Golbaz, G. Stock, A. Fous, S. Kolar, C. Pruente, and U. Schmidt-Erfurth, “Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration,” Ophthalmology 115, e39–46 (2008).
[Crossref] [PubMed]

Fujimoto, J. G.

W. Drexler and J. G. Fujimoto, “State-of-the-art retinal optical coherence tomography,” Prog Retin Eye Res 27, 45–88 (2008).
[Crossref]

M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
[Crossref] [PubMed]

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

V. J. Srinivasan, M. Wojtkowski, A. J. Witkin, J. S. Duker, T. H. Ko, M. Carvalho, J. S. Schuman, A. Kowalczyk, and J. G. Fujimoto, “High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 113, 2054 e2051–2014 (2006).
[Crossref]

C. G. Pieroni, A. J. Witkin, T. H. Ko, J. G. Fujimoto, A. Chan, J. S. Schuman, H. Ishikawa, E. Reichel, and J. S. Duker, “Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration,” Br J Ophthalmol 90, 191–197 (2006).
[Crossref] [PubMed]

M. Wojtkowski, V. Srinivasan, J. G. Fujimoto, T. Ko, J. S. Schuman, A. Kowalczyk, and J. S. Duker, “Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 112, 1734–1746 (2005).
[Crossref] [PubMed]

T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
[Crossref]

M. R. Hee, C. A. Puliafito, C. Wong, J. S. Duker, E. Reichel, B. Rutledge, J. S. Schuman, E. A. Swanson, and J. G. Fujimoto, “Quantitative assessment of macular edema with optical coherence tomography,” Arch Ophthalmol 113, 1019–1029 (1995).
[PubMed]

C. A. Puliafito, M. R. Hee, C. P. Lin, E. Reichel, J. S. Schuman, J. S. Duker, J. A. Izatt, E. A. Swanson, and J. G. Fujimoto, “Imaging of macular diseases with optical coherence tomography,” Ophthalmology 102, 217–229 (1995).
[PubMed]

M. R. Hee, J. A. Izatt, E. A. Swanson, D. Huang, J. S. Schuman, C. P. Lin, C. A. Puliafito, and J. G. Fujimoto, “Optical coherence tomography of the human retina,” Arch Ophthalmol 113, 325–332 (1995).
[PubMed]

Fung, A. E.

A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
[Crossref] [PubMed]

Gabriele, M. L.

M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
[Crossref] [PubMed]

Gaudric, A.

U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
[Crossref] [PubMed]

Geitzenauer, W.

C. Ahlers, C. Simader, W. Geitzenauer, G. Stock, P. Stetson, S. Dastmalchi, and U. Schmidt-Erfurth, “Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography,” Br J Ophthalmol 92, 197–203 (2008).
[Crossref]

George, R

P Sen, A Bhargava, L Vijaya, and R George, “Prevalence of idiopathic macular hole in adult rural and urban south Indian population,” Clin Experiment Ophthalmol. 36, 257–260 (2008).
[Crossref] [PubMed]

Gerber, H. P.

N. Ferrara, H. P. Gerber, and J. LeCouter, “The biology of VEGF and its receptors,” Nat Med 9, 669–676 (2003).
[Crossref] [PubMed]

Giovannini, A.

A. Giovannini, G. Amato, and C. Mariotti, “The macular thickness and volume in glaucoma: an analysis in normal and glaucomatous eyes using OCT,” Acta Ophthalmol Scand Suppl 236, 34–36 (2002).
[Crossref] [PubMed]

Golbaz, I.

C. Ahlers, I. Golbaz, G. Stock, A. Fous, S. Kolar, C. Pruente, and U. Schmidt-Erfurth, “Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration,” Ophthalmology 115, e39–46 (2008).
[Crossref] [PubMed]

Gotoh, N.

Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
[Crossref] [PubMed]

Gregory, K.

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
[Crossref] [PubMed]

Haller, J. A.

A. Polito, S. M. Shah, J. A. Haller, I. Zimmer-Galler, R. Zeimer, P. A. Campochiaro, and S. Vitale, “Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease,” Am J Ophthalmol 134, 240–251 (2002).
[Crossref] [PubMed]

Hangai, M.

Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
[Crossref] [PubMed]

Hartl, I.

T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
[Crossref]

Hee, M. R.

M. R. Hee, C. A. Puliafito, C. Wong, J. S. Duker, E. Reichel, B. Rutledge, J. S. Schuman, E. A. Swanson, and J. G. Fujimoto, “Quantitative assessment of macular edema with optical coherence tomography,” Arch Ophthalmol 113, 1019–1029 (1995).
[PubMed]

M. R. Hee, J. A. Izatt, E. A. Swanson, D. Huang, J. S. Schuman, C. P. Lin, C. A. Puliafito, and J. G. Fujimoto, “Optical coherence tomography of the human retina,” Arch Ophthalmol 113, 325–332 (1995).
[PubMed]

C. A. Puliafito, M. R. Hee, C. P. Lin, E. Reichel, J. S. Schuman, J. S. Duker, J. A. Izatt, E. A. Swanson, and J. G. Fujimoto, “Imaging of macular diseases with optical coherence tomography,” Ophthalmology 102, 217–229 (1995).
[PubMed]

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
[Crossref] [PubMed]

Heier, J. S.

D. M. Brown, P. K. Kaiser, M. Michels, G. Soubrane, J. S. Heier, R. Y. Kim, J. P. Sy, and S. Schneider, “Ranibizumab versus verteporfin for neovascular age-related macular degeneration,” N Engl J Med 355, 1432–1444 (2006).
[Crossref] [PubMed]

P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, and R. Y. Kim, “Ranibizumab for neovascular age-related macular degeneration,” N Engl J Med 355, 1419–1431 (2006).
[Crossref] [PubMed]

Helb, HM

M Fleckenstein, P Charbel Issa, HM Helb, S Schmitz-Valckenberg, RP Finger, HP Scholl, KU Loeffler, and FG Holz. “High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration” Invest Ophthalmol Vis Sci. 49, 4137–4144 (2008). Epub 2008 May 16.
[Crossref] [PubMed]

Hermann, B.

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

Holz, FG

M Fleckenstein, P Charbel Issa, HM Helb, S Schmitz-Valckenberg, RP Finger, HP Scholl, KU Loeffler, and FG Holz. “High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration” Invest Ophthalmol Vis Sci. 49, 4137–4144 (2008). Epub 2008 May 16.
[Crossref] [PubMed]

Hsu, W. M.

C. S. Yang, C. Y. Cheng, F. L. Lee, W. M. Hsu, and J. H. Liu, “Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography,” Acta Ophthalmol Scand 79, 266–270 (2001).
[Crossref] [PubMed]

Huang, D.

M. R. Hee, J. A. Izatt, E. A. Swanson, D. Huang, J. S. Schuman, C. P. Lin, C. A. Puliafito, and J. G. Fujimoto, “Optical coherence tomography of the human retina,” Arch Ophthalmol 113, 325–332 (1995).
[PubMed]

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
[Crossref] [PubMed]

Ikeji, F.

P. J. Patel, F. K. Chen, F. Ikeji, W. Xing, C. Bunce, L. Da Cruz, and A. Tufail, “Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration,” Invest Ophthalmol Vis Sci 49, 1084–1088 (2008).
[Crossref] [PubMed]

Inoue, R.

Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
[Crossref] [PubMed]

Ishikawa, H.

M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
[Crossref] [PubMed]

C. G. Pieroni, A. J. Witkin, T. H. Ko, J. G. Fujimoto, A. Chan, J. S. Schuman, H. Ishikawa, E. Reichel, and J. S. Duker, “Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration,” Br J Ophthalmol 90, 191–197 (2006).
[Crossref] [PubMed]

T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
[Crossref]

Izatt, J. A.

C. A. Puliafito, M. R. Hee, C. P. Lin, E. Reichel, J. S. Schuman, J. S. Duker, J. A. Izatt, E. A. Swanson, and J. G. Fujimoto, “Imaging of macular diseases with optical coherence tomography,” Ophthalmology 102, 217–229 (1995).
[PubMed]

M. R. Hee, J. A. Izatt, E. A. Swanson, D. Huang, J. S. Schuman, C. P. Lin, C. A. Puliafito, and J. G. Fujimoto, “Optical coherence tomography of the human retina,” Arch Ophthalmol 113, 325–332 (1995).
[PubMed]

Kagemann, L.

M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
[Crossref] [PubMed]

Kaiser, P. K.

P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, and R. Y. Kim, “Ranibizumab for neovascular age-related macular degeneration,” N Engl J Med 355, 1419–1431 (2006).
[Crossref] [PubMed]

D. M. Brown, P. K. Kaiser, M. Michels, G. Soubrane, J. S. Heier, R. Y. Kim, J. P. Sy, and S. Schneider, “Ranibizumab versus verteporfin for neovascular age-related macular degeneration,” N Engl J Med 355, 1432–1444 (2006).
[Crossref] [PubMed]

Kim, R. Y.

D. M. Brown, P. K. Kaiser, M. Michels, G. Soubrane, J. S. Heier, R. Y. Kim, J. P. Sy, and S. Schneider, “Ranibizumab versus verteporfin for neovascular age-related macular degeneration,” N Engl J Med 355, 1432–1444 (2006).
[Crossref] [PubMed]

P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, and R. Y. Kim, “Ranibizumab for neovascular age-related macular degeneration,” N Engl J Med 355, 1419–1431 (2006).
[Crossref] [PubMed]

Ko, T.

M. Wojtkowski, V. Srinivasan, J. G. Fujimoto, T. Ko, J. S. Schuman, A. Kowalczyk, and J. S. Duker, “Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 112, 1734–1746 (2005).
[Crossref] [PubMed]

Ko, T. H.

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

V. J. Srinivasan, M. Wojtkowski, A. J. Witkin, J. S. Duker, T. H. Ko, M. Carvalho, J. S. Schuman, A. Kowalczyk, and J. G. Fujimoto, “High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 113, 2054 e2051–2014 (2006).
[Crossref]

C. G. Pieroni, A. J. Witkin, T. H. Ko, J. G. Fujimoto, A. Chan, J. S. Schuman, H. Ishikawa, E. Reichel, and J. S. Duker, “Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration,” Br J Ophthalmol 90, 191–197 (2006).
[Crossref] [PubMed]

T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
[Crossref]

Kolar, S.

C. Ahlers, I. Golbaz, G. Stock, A. Fous, S. Kolar, C. Pruente, and U. Schmidt-Erfurth, “Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration,” Ophthalmology 115, e39–46 (2008).
[Crossref] [PubMed]

Kowalczyk, A.

V. J. Srinivasan, M. Wojtkowski, A. J. Witkin, J. S. Duker, T. H. Ko, M. Carvalho, J. S. Schuman, A. Kowalczyk, and J. G. Fujimoto, “High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 113, 2054 e2051–2014 (2006).
[Crossref]

M. Wojtkowski, V. Srinivasan, J. G. Fujimoto, T. Ko, J. S. Schuman, A. Kowalczyk, and J. S. Duker, “Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 112, 1734–1746 (2005).
[Crossref] [PubMed]

Kowalevicz, A. M.

T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
[Crossref]

LaBree, L. D.

S. R. Sadda, Z. Wu, A. C. Walsh, L. Richine, J. Dougall, R. Cortez, and L. D. LaBree, “Errors in retinal thickness measurements obtained by optical coherence tomography,” Ophthalmology 113, 285–293 (2006).
[Crossref] [PubMed]

Lalwani, G. A.

A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
[Crossref] [PubMed]

LeCouter, J.

N. Ferrara, H. P. Gerber, and J. LeCouter, “The biology of VEGF and its receptors,” Nat Med 9, 669–676 (2003).
[Crossref] [PubMed]

Lee, F. L.

C. S. Yang, C. Y. Cheng, F. L. Lee, W. M. Hsu, and J. H. Liu, “Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography,” Acta Ophthalmol Scand 79, 266–270 (2001).
[Crossref] [PubMed]

Lee, J. E.

N. Villate, J. E. Lee, A. Venkatraman, and W. E. Smiddy, “Photoreceptor layer features in eyes with closed macular holes: optical coherence tomography findings and correlation with visual outcomes,” Am J Ophthalmol 139, 280–289 (2005).
[Crossref] [PubMed]

Leitgeb, R. A.

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

Lem, J.

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

Leys, A.

U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
[Crossref] [PubMed]

Lin, C. P.

M. R. Hee, J. A. Izatt, E. A. Swanson, D. Huang, J. S. Schuman, C. P. Lin, C. A. Puliafito, and J. G. Fujimoto, “Optical coherence tomography of the human retina,” Arch Ophthalmol 113, 325–332 (1995).
[PubMed]

C. A. Puliafito, M. R. Hee, C. P. Lin, E. Reichel, J. S. Schuman, J. S. Duker, J. A. Izatt, E. A. Swanson, and J. G. Fujimoto, “Imaging of macular diseases with optical coherence tomography,” Ophthalmology 102, 217–229 (1995).
[PubMed]

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
[Crossref] [PubMed]

Liu, J. H.

C. S. Yang, C. Y. Cheng, F. L. Lee, W. M. Hsu, and J. H. Liu, “Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography,” Acta Ophthalmol Scand 79, 266–270 (2001).
[Crossref] [PubMed]

Loeffler, KU

M Fleckenstein, P Charbel Issa, HM Helb, S Schmitz-Valckenberg, RP Finger, HP Scholl, KU Loeffler, and FG Holz. “High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration” Invest Ophthalmol Vis Sci. 49, 4137–4144 (2008). Epub 2008 May 16.
[Crossref] [PubMed]

Makita, S.

Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
[Crossref] [PubMed]

Mariotti, C.

A. Giovannini, G. Amato, and C. Mariotti, “The macular thickness and volume in glaucoma: an analysis in normal and glaucomatous eyes using OCT,” Acta Ophthalmol Scand Suppl 236, 34–36 (2002).
[Crossref] [PubMed]

Michalewska, Z.

J. Michalewski, Z. Michalewska, S. Cisiecki, and J. Nawrocki, “Morphologically functional correlations of macular pathology connected with epiretinal membrane formation in spectral optical coherence tomography (SOCT),” Graefes Arch Clin Exp Ophthalmol 245, 1623–1631 (2007).
[Crossref] [PubMed]

Michalewski, J.

J. Michalewski, Z. Michalewska, S. Cisiecki, and J. Nawrocki, “Morphologically functional correlations of macular pathology connected with epiretinal membrane formation in spectral optical coherence tomography (SOCT),” Graefes Arch Clin Exp Ophthalmol 245, 1623–1631 (2007).
[Crossref] [PubMed]

Michels, M.

D. M. Brown, P. K. Kaiser, M. Michels, G. Soubrane, J. S. Heier, R. Y. Kim, J. P. Sy, and S. Schneider, “Ranibizumab versus verteporfin for neovascular age-related macular degeneration,” N Engl J Med 355, 1432–1444 (2006).
[Crossref] [PubMed]

Michels, S.

A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
[Crossref] [PubMed]

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

Nawrocki, J.

J. Michalewski, Z. Michalewska, S. Cisiecki, and J. Nawrocki, “Morphologically functional correlations of macular pathology connected with epiretinal membrane formation in spectral optical coherence tomography (SOCT),” Graefes Arch Clin Exp Ophthalmol 245, 1623–1631 (2007).
[Crossref] [PubMed]

Ogura, Y.

M. Shahidi, Y. Ogura, N. P. Blair, M. M. Rusin, and R. Zeimer, “Retinal thickness analysis for quantitative assessment of diabetic macular edema,” Arch Ophthalmol 109, 1115–1119 (1991).
[PubMed]

Ojima, Y.

Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
[Crossref] [PubMed]

Patel, P. J.

P. J. Patel, F. K. Chen, L. da Cruz, and A. Tufail, “Segmentation Error in Stratus Optical Coherence Tomography for Neovascular Age-related Macular Degeneration,” Invest Ophthalmol Vis Sci. 50, 399–404 (2008).
[Crossref] [PubMed]

P. J. Patel, F. K. Chen, F. Ikeji, W. Xing, C. Bunce, L. Da Cruz, and A. Tufail, “Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration,” Invest Ophthalmol Vis Sci 49, 1084–1088 (2008).
[Crossref] [PubMed]

Paunescu, L. A.

T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
[Crossref]

Pieroni, C. G.

C. G. Pieroni, A. J. Witkin, T. H. Ko, J. G. Fujimoto, A. Chan, J. S. Schuman, H. Ishikawa, E. Reichel, and J. S. Duker, “Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration,” Br J Ophthalmol 90, 191–197 (2006).
[Crossref] [PubMed]

Polito, A.

A. Polito, S. M. Shah, J. A. Haller, I. Zimmer-Galler, R. Zeimer, P. A. Campochiaro, and S. Vitale, “Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease,” Am J Ophthalmol 134, 240–251 (2002).
[Crossref] [PubMed]

Povazay, B.

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

Pruente, C.

C. Ahlers, I. Golbaz, G. Stock, A. Fous, S. Kolar, C. Pruente, and U. Schmidt-Erfurth, “Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration,” Ophthalmology 115, e39–46 (2008).
[Crossref] [PubMed]

U. M. Schmidt-Erfurth and C. Pruente, “Management of neovascular age-related macular degeneration,” Prog Retin Eye Res 26, 437–451 (2007).
[Crossref] [PubMed]

Puliafito, C. A.

A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
[Crossref] [PubMed]

G. M. Somfai, H. M. Salinas, C. A. Puliafito, and D. C. Fernandez, “Evaluation of potential image acquisition pitfalls during optical coherence tomography and their influence on retinal image segmentation,” J Biomed Opt 12, 041209 (2007).
[Crossref] [PubMed]

M. R. Hee, C. A. Puliafito, C. Wong, J. S. Duker, E. Reichel, B. Rutledge, J. S. Schuman, E. A. Swanson, and J. G. Fujimoto, “Quantitative assessment of macular edema with optical coherence tomography,” Arch Ophthalmol 113, 1019–1029 (1995).
[PubMed]

M. R. Hee, J. A. Izatt, E. A. Swanson, D. Huang, J. S. Schuman, C. P. Lin, C. A. Puliafito, and J. G. Fujimoto, “Optical coherence tomography of the human retina,” Arch Ophthalmol 113, 325–332 (1995).
[PubMed]

C. A. Puliafito, M. R. Hee, C. P. Lin, E. Reichel, J. S. Schuman, J. S. Duker, J. A. Izatt, E. A. Swanson, and J. G. Fujimoto, “Imaging of macular diseases with optical coherence tomography,” Ophthalmology 102, 217–229 (1995).
[PubMed]

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
[Crossref] [PubMed]

Reichel, E.

C. G. Pieroni, A. J. Witkin, T. H. Ko, J. G. Fujimoto, A. Chan, J. S. Schuman, H. Ishikawa, E. Reichel, and J. S. Duker, “Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration,” Br J Ophthalmol 90, 191–197 (2006).
[Crossref] [PubMed]

M. R. Hee, C. A. Puliafito, C. Wong, J. S. Duker, E. Reichel, B. Rutledge, J. S. Schuman, E. A. Swanson, and J. G. Fujimoto, “Quantitative assessment of macular edema with optical coherence tomography,” Arch Ophthalmol 113, 1019–1029 (1995).
[PubMed]

C. A. Puliafito, M. R. Hee, C. P. Lin, E. Reichel, J. S. Schuman, J. S. Duker, J. A. Izatt, E. A. Swanson, and J. G. Fujimoto, “Imaging of macular diseases with optical coherence tomography,” Ophthalmology 102, 217–229 (1995).
[PubMed]

Richard, G.

U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
[Crossref] [PubMed]

Richine, L.

S. R. Sadda, Z. Wu, A. C. Walsh, L. Richine, J. Dougall, R. Cortez, and L. D. LaBree, “Errors in retinal thickness measurements obtained by optical coherence tomography,” Ophthalmology 113, 285–293 (2006).
[Crossref] [PubMed]

Rosenfeld, P. J.

A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
[Crossref] [PubMed]

P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, and R. Y. Kim, “Ranibizumab for neovascular age-related macular degeneration,” N Engl J Med 355, 1419–1431 (2006).
[Crossref] [PubMed]

Rusin, M. M.

M. Shahidi, Y. Ogura, N. P. Blair, M. M. Rusin, and R. Zeimer, “Retinal thickness analysis for quantitative assessment of diabetic macular edema,” Arch Ophthalmol 109, 1115–1119 (1991).
[PubMed]

Rutledge, B.

M. R. Hee, C. A. Puliafito, C. Wong, J. S. Duker, E. Reichel, B. Rutledge, J. S. Schuman, E. A. Swanson, and J. G. Fujimoto, “Quantitative assessment of macular edema with optical coherence tomography,” Arch Ophthalmol 113, 1019–1029 (1995).
[PubMed]

Sacu, S.

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

Sadda, S. R.

S. R. Sadda, Z. Wu, A. C. Walsh, L. Richine, J. Dougall, R. Cortez, and L. D. LaBree, “Errors in retinal thickness measurements obtained by optical coherence tomography,” Ophthalmology 113, 285–293 (2006).
[Crossref] [PubMed]

Salinas, H. M.

G. M. Somfai, H. M. Salinas, C. A. Puliafito, and D. C. Fernandez, “Evaluation of potential image acquisition pitfalls during optical coherence tomography and their influence on retinal image segmentation,” J Biomed Opt 12, 041209 (2007).
[Crossref] [PubMed]

Sasahara, M.

Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
[Crossref] [PubMed]

Sattmann, H.

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

Schlingemann, R. O.

U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
[Crossref] [PubMed]

Schmidt-Erfurth, U.

C. Ahlers, I. Golbaz, G. Stock, A. Fous, S. Kolar, C. Pruente, and U. Schmidt-Erfurth, “Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration,” Ophthalmology 115, e39–46 (2008).
[Crossref] [PubMed]

C. Ahlers, C. Simader, W. Geitzenauer, G. Stock, P. Stetson, S. Dastmalchi, and U. Schmidt-Erfurth, “Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography,” Br J Ophthalmol 92, 197–203 (2008).
[Crossref]

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

Schmidt-Erfurth, U. M.

U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
[Crossref] [PubMed]

U. M. Schmidt-Erfurth and C. Pruente, “Management of neovascular age-related macular degeneration,” Prog Retin Eye Res 26, 437–451 (2007).
[Crossref] [PubMed]

Schmitz-Valckenberg, S

M Fleckenstein, P Charbel Issa, HM Helb, S Schmitz-Valckenberg, RP Finger, HP Scholl, KU Loeffler, and FG Holz. “High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration” Invest Ophthalmol Vis Sci. 49, 4137–4144 (2008). Epub 2008 May 16.
[Crossref] [PubMed]

Schneider, S.

D. M. Brown, P. K. Kaiser, M. Michels, G. Soubrane, J. S. Heier, R. Y. Kim, J. P. Sy, and S. Schneider, “Ranibizumab versus verteporfin for neovascular age-related macular degeneration,” N Engl J Med 355, 1432–1444 (2006).
[Crossref] [PubMed]

Scholda, C.

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

Scholl, HP

M Fleckenstein, P Charbel Issa, HM Helb, S Schmitz-Valckenberg, RP Finger, HP Scholl, KU Loeffler, and FG Holz. “High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration” Invest Ophthalmol Vis Sci. 49, 4137–4144 (2008). Epub 2008 May 16.
[Crossref] [PubMed]

Schuman, J. S.

M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
[Crossref] [PubMed]

V. J. Srinivasan, M. Wojtkowski, A. J. Witkin, J. S. Duker, T. H. Ko, M. Carvalho, J. S. Schuman, A. Kowalczyk, and J. G. Fujimoto, “High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 113, 2054 e2051–2014 (2006).
[Crossref]

C. G. Pieroni, A. J. Witkin, T. H. Ko, J. G. Fujimoto, A. Chan, J. S. Schuman, H. Ishikawa, E. Reichel, and J. S. Duker, “Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration,” Br J Ophthalmol 90, 191–197 (2006).
[Crossref] [PubMed]

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

M. Wojtkowski, V. Srinivasan, J. G. Fujimoto, T. Ko, J. S. Schuman, A. Kowalczyk, and J. S. Duker, “Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 112, 1734–1746 (2005).
[Crossref] [PubMed]

T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
[Crossref]

M. R. Hee, C. A. Puliafito, C. Wong, J. S. Duker, E. Reichel, B. Rutledge, J. S. Schuman, E. A. Swanson, and J. G. Fujimoto, “Quantitative assessment of macular edema with optical coherence tomography,” Arch Ophthalmol 113, 1019–1029 (1995).
[PubMed]

C. A. Puliafito, M. R. Hee, C. P. Lin, E. Reichel, J. S. Schuman, J. S. Duker, J. A. Izatt, E. A. Swanson, and J. G. Fujimoto, “Imaging of macular diseases with optical coherence tomography,” Ophthalmology 102, 217–229 (1995).
[PubMed]

M. R. Hee, J. A. Izatt, E. A. Swanson, D. Huang, J. S. Schuman, C. P. Lin, C. A. Puliafito, and J. G. Fujimoto, “Optical coherence tomography of the human retina,” Arch Ophthalmol 113, 325–332 (1995).
[PubMed]

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
[Crossref] [PubMed]

Sen, P

P Sen, A Bhargava, L Vijaya, and R George, “Prevalence of idiopathic macular hole in adult rural and urban south Indian population,” Clin Experiment Ophthalmol. 36, 257–260 (2008).
[Crossref] [PubMed]

Shah, S. M.

A. Polito, S. M. Shah, J. A. Haller, I. Zimmer-Galler, R. Zeimer, P. A. Campochiaro, and S. Vitale, “Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease,” Am J Ophthalmol 134, 240–251 (2002).
[Crossref] [PubMed]

Shahidi, M.

M. Shahidi, Y. Ogura, N. P. Blair, M. M. Rusin, and R. Zeimer, “Retinal thickness analysis for quantitative assessment of diabetic macular edema,” Arch Ophthalmol 109, 1115–1119 (1991).
[PubMed]

Simader, C.

C. Ahlers, C. Simader, W. Geitzenauer, G. Stock, P. Stetson, S. Dastmalchi, and U. Schmidt-Erfurth, “Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography,” Br J Ophthalmol 92, 197–203 (2008).
[Crossref]

Smiddy, W. E.

N. Villate, J. E. Lee, A. Venkatraman, and W. E. Smiddy, “Photoreceptor layer features in eyes with closed macular holes: optical coherence tomography findings and correlation with visual outcomes,” Am J Ophthalmol 139, 280–289 (2005).
[Crossref] [PubMed]

Somfai, G. M.

G. M. Somfai, H. M. Salinas, C. A. Puliafito, and D. C. Fernandez, “Evaluation of potential image acquisition pitfalls during optical coherence tomography and their influence on retinal image segmentation,” J Biomed Opt 12, 041209 (2007).
[Crossref] [PubMed]

Song, Q. H.

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

Soubrane, G.

D. M. Brown, P. K. Kaiser, M. Michels, G. Soubrane, J. S. Heier, R. Y. Kim, J. P. Sy, and S. Schneider, “Ranibizumab versus verteporfin for neovascular age-related macular degeneration,” N Engl J Med 355, 1432–1444 (2006).
[Crossref] [PubMed]

Srinivasan, V.

M. Wojtkowski, V. Srinivasan, J. G. Fujimoto, T. Ko, J. S. Schuman, A. Kowalczyk, and J. S. Duker, “Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 112, 1734–1746 (2005).
[Crossref] [PubMed]

Srinivasan, V. J.

M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
[Crossref] [PubMed]

V. J. Srinivasan, M. Wojtkowski, A. J. Witkin, J. S. Duker, T. H. Ko, M. Carvalho, J. S. Schuman, A. Kowalczyk, and J. G. Fujimoto, “High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 113, 2054 e2051–2014 (2006).
[Crossref]

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

Stetson, P.

C. Ahlers, C. Simader, W. Geitzenauer, G. Stock, P. Stetson, S. Dastmalchi, and U. Schmidt-Erfurth, “Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography,” Br J Ophthalmol 92, 197–203 (2008).
[Crossref]

Stinson, W. G.

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
[Crossref] [PubMed]

Stock, G.

C. Ahlers, C. Simader, W. Geitzenauer, G. Stock, P. Stetson, S. Dastmalchi, and U. Schmidt-Erfurth, “Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography,” Br J Ophthalmol 92, 197–203 (2008).
[Crossref]

C. Ahlers, I. Golbaz, G. Stock, A. Fous, S. Kolar, C. Pruente, and U. Schmidt-Erfurth, “Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration,” Ophthalmology 115, e39–46 (2008).
[Crossref] [PubMed]

Swanson, E. A.

M. R. Hee, C. A. Puliafito, C. Wong, J. S. Duker, E. Reichel, B. Rutledge, J. S. Schuman, E. A. Swanson, and J. G. Fujimoto, “Quantitative assessment of macular edema with optical coherence tomography,” Arch Ophthalmol 113, 1019–1029 (1995).
[PubMed]

M. R. Hee, J. A. Izatt, E. A. Swanson, D. Huang, J. S. Schuman, C. P. Lin, C. A. Puliafito, and J. G. Fujimoto, “Optical coherence tomography of the human retina,” Arch Ophthalmol 113, 325–332 (1995).
[PubMed]

C. A. Puliafito, M. R. Hee, C. P. Lin, E. Reichel, J. S. Schuman, J. S. Duker, J. A. Izatt, E. A. Swanson, and J. G. Fujimoto, “Imaging of macular diseases with optical coherence tomography,” Ophthalmology 102, 217–229 (1995).
[PubMed]

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
[Crossref] [PubMed]

Sy, J. P.

D. M. Brown, P. K. Kaiser, M. Michels, G. Soubrane, J. S. Heier, R. Y. Kim, J. P. Sy, and S. Schneider, “Ranibizumab versus verteporfin for neovascular age-related macular degeneration,” N Engl J Med 355, 1432–1444 (2006).
[Crossref] [PubMed]

Tsujikawa, A.

Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
[Crossref] [PubMed]

Tufail, A.

P. J. Patel, F. K. Chen, F. Ikeji, W. Xing, C. Bunce, L. Da Cruz, and A. Tufail, “Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration,” Invest Ophthalmol Vis Sci 49, 1084–1088 (2008).
[Crossref] [PubMed]

P. J. Patel, F. K. Chen, L. da Cruz, and A. Tufail, “Segmentation Error in Stratus Optical Coherence Tomography for Neovascular Age-related Macular Degeneration,” Invest Ophthalmol Vis Sci. 50, 399–404 (2008).
[Crossref] [PubMed]

van Leeuwen, T. G.

M. E. van Velthoven, D. J. Faber, F. D. Verbraak, T. G. van Leeuwen, and M. D. de Smet, “Recent developments in optical coherence tomography for imaging the retina,” Prog Retin Eye Res 26, 57–77 (2007).
[Crossref]

van Velthoven, M. E.

M. E. van Velthoven, D. J. Faber, F. D. Verbraak, T. G. van Leeuwen, and M. D. de Smet, “Recent developments in optical coherence tomography for imaging the retina,” Prog Retin Eye Res 26, 57–77 (2007).
[Crossref]

Venkatraman, A.

N. Villate, J. E. Lee, A. Venkatraman, and W. E. Smiddy, “Photoreceptor layer features in eyes with closed macular holes: optical coherence tomography findings and correlation with visual outcomes,” Am J Ophthalmol 139, 280–289 (2005).
[Crossref] [PubMed]

Verbraak, F. D.

M. E. van Velthoven, D. J. Faber, F. D. Verbraak, T. G. van Leeuwen, and M. D. de Smet, “Recent developments in optical coherence tomography for imaging the retina,” Prog Retin Eye Res 26, 57–77 (2007).
[Crossref]

Vijaya, L

P Sen, A Bhargava, L Vijaya, and R George, “Prevalence of idiopathic macular hole in adult rural and urban south Indian population,” Clin Experiment Ophthalmol. 36, 257–260 (2008).
[Crossref] [PubMed]

Villate, N.

N. Villate, J. E. Lee, A. Venkatraman, and W. E. Smiddy, “Photoreceptor layer features in eyes with closed macular holes: optical coherence tomography findings and correlation with visual outcomes,” Am J Ophthalmol 139, 280–289 (2005).
[Crossref] [PubMed]

Vitale, S.

A. Polito, S. M. Shah, J. A. Haller, I. Zimmer-Galler, R. Zeimer, P. A. Campochiaro, and S. Vitale, “Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease,” Am J Ophthalmol 134, 240–251 (2002).
[Crossref] [PubMed]

Walsh, A. C.

S. R. Sadda, Z. Wu, A. C. Walsh, L. Richine, J. Dougall, R. Cortez, and L. D. LaBree, “Errors in retinal thickness measurements obtained by optical coherence tomography,” Ophthalmology 113, 285–293 (2006).
[Crossref] [PubMed]

Witkin, A. J.

V. J. Srinivasan, M. Wojtkowski, A. J. Witkin, J. S. Duker, T. H. Ko, M. Carvalho, J. S. Schuman, A. Kowalczyk, and J. G. Fujimoto, “High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 113, 2054 e2051–2014 (2006).
[Crossref]

C. G. Pieroni, A. J. Witkin, T. H. Ko, J. G. Fujimoto, A. Chan, J. S. Schuman, H. Ishikawa, E. Reichel, and J. S. Duker, “Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration,” Br J Ophthalmol 90, 191–197 (2006).
[Crossref] [PubMed]

Wojtkowski, M.

M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
[Crossref] [PubMed]

V. J. Srinivasan, M. Wojtkowski, A. J. Witkin, J. S. Duker, T. H. Ko, M. Carvalho, J. S. Schuman, A. Kowalczyk, and J. G. Fujimoto, “High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 113, 2054 e2051–2014 (2006).
[Crossref]

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

M. Wojtkowski, V. Srinivasan, J. G. Fujimoto, T. Ko, J. S. Schuman, A. Kowalczyk, and J. S. Duker, “Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 112, 1734–1746 (2005).
[Crossref] [PubMed]

Wolf, S

UE Wolf-Schnurrbusch, V Enzmann, CK Brinkmann, and S Wolf “Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination” Invest Ophthalmol Vis Sci. 49, 3095–3099 (2008). Epub 2008 Mar 31.
[Crossref] [PubMed]

Wolf-Schnurrbusch, UE

UE Wolf-Schnurrbusch, V Enzmann, CK Brinkmann, and S Wolf “Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination” Invest Ophthalmol Vis Sci. 49, 3095–3099 (2008). Epub 2008 Mar 31.
[Crossref] [PubMed]

Wollstein, G.

M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
[Crossref] [PubMed]

T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
[Crossref]

Wong, C.

M. R. Hee, C. A. Puliafito, C. Wong, J. S. Duker, E. Reichel, B. Rutledge, J. S. Schuman, E. A. Swanson, and J. G. Fujimoto, “Quantitative assessment of macular edema with optical coherence tomography,” Arch Ophthalmol 113, 1019–1029 (1995).
[PubMed]

Wu, Z.

S. R. Sadda, Z. Wu, A. C. Walsh, L. Richine, J. Dougall, R. Cortez, and L. D. LaBree, “Errors in retinal thickness measurements obtained by optical coherence tomography,” Ophthalmology 113, 285–293 (2006).
[Crossref] [PubMed]

Xing, W.

P. J. Patel, F. K. Chen, F. Ikeji, W. Xing, C. Bunce, L. Da Cruz, and A. Tufail, “Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration,” Invest Ophthalmol Vis Sci 49, 1084–1088 (2008).
[Crossref] [PubMed]

Yang, C. S.

C. S. Yang, C. Y. Cheng, F. L. Lee, W. M. Hsu, and J. H. Liu, “Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography,” Acta Ophthalmol Scand 79, 266–270 (2001).
[Crossref] [PubMed]

Yasuno, Y.

Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
[Crossref] [PubMed]

Yatagai, T.

Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
[Crossref] [PubMed]

Yoshimura, N.

Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
[Crossref] [PubMed]

Zeimer, R.

A. Polito, S. M. Shah, J. A. Haller, I. Zimmer-Galler, R. Zeimer, P. A. Campochiaro, and S. Vitale, “Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease,” Am J Ophthalmol 134, 240–251 (2002).
[Crossref] [PubMed]

M. Shahidi, Y. Ogura, N. P. Blair, M. M. Rusin, and R. Zeimer, “Retinal thickness analysis for quantitative assessment of diabetic macular edema,” Arch Ophthalmol 109, 1115–1119 (1991).
[PubMed]

Zimmer-Galler, I.

A. Polito, S. M. Shah, J. A. Haller, I. Zimmer-Galler, R. Zeimer, P. A. Campochiaro, and S. Vitale, “Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease,” Am J Ophthalmol 134, 240–251 (2002).
[Crossref] [PubMed]

Acta Ophthalmol Scand (2)

C. S. Yang, C. Y. Cheng, F. L. Lee, W. M. Hsu, and J. H. Liu, “Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography,” Acta Ophthalmol Scand 79, 266–270 (2001).
[Crossref] [PubMed]

U. M. Schmidt-Erfurth, G. Richard, A. Augustin, W. G. Aylward, F. Bandello, B. Corcostegui, J. Cunha-Vaz, A. Gaudric, A. Leys, and R. O. Schlingemann, “Guidance for the treatment of neovascular age-related macular degeneration,” Acta Ophthalmol Scand 85, 486–494 (2007).
[Crossref] [PubMed]

Acta Ophthalmol Scand Suppl (1)

A. Giovannini, G. Amato, and C. Mariotti, “The macular thickness and volume in glaucoma: an analysis in normal and glaucomatous eyes using OCT,” Acta Ophthalmol Scand Suppl 236, 34–36 (2002).
[Crossref] [PubMed]

Am J Ophthalmol (3)

A. Polito, S. M. Shah, J. A. Haller, I. Zimmer-Galler, R. Zeimer, P. A. Campochiaro, and S. Vitale, “Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease,” Am J Ophthalmol 134, 240–251 (2002).
[Crossref] [PubMed]

A. E. Fung, G. A. Lalwani, P. J. Rosenfeld, S. R. Dubovy, S. Michels, W. J. Feuer, C. A. Puliafito, J. L. Davis, H. W. Flynn, Jr., and M. Esquiabro, “An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” Am J Ophthalmol 143, 566–583 (2007).
[Crossref] [PubMed]

N. Villate, J. E. Lee, A. Venkatraman, and W. E. Smiddy, “Photoreceptor layer features in eyes with closed macular holes: optical coherence tomography findings and correlation with visual outcomes,” Am J Ophthalmol 139, 280–289 (2005).
[Crossref] [PubMed]

Arch Ophthalmol (3)

M. R. Hee, J. A. Izatt, E. A. Swanson, D. Huang, J. S. Schuman, C. P. Lin, C. A. Puliafito, and J. G. Fujimoto, “Optical coherence tomography of the human retina,” Arch Ophthalmol 113, 325–332 (1995).
[PubMed]

M. R. Hee, C. A. Puliafito, C. Wong, J. S. Duker, E. Reichel, B. Rutledge, J. S. Schuman, E. A. Swanson, and J. G. Fujimoto, “Quantitative assessment of macular edema with optical coherence tomography,” Arch Ophthalmol 113, 1019–1029 (1995).
[PubMed]

M. Shahidi, Y. Ogura, N. P. Blair, M. M. Rusin, and R. Zeimer, “Retinal thickness analysis for quantitative assessment of diabetic macular edema,” Arch Ophthalmol 109, 1115–1119 (1991).
[PubMed]

Br J Ophthalmol (2)

C. G. Pieroni, A. J. Witkin, T. H. Ko, J. G. Fujimoto, A. Chan, J. S. Schuman, H. Ishikawa, E. Reichel, and J. S. Duker, “Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration,” Br J Ophthalmol 90, 191–197 (2006).
[Crossref] [PubMed]

C. Ahlers, C. Simader, W. Geitzenauer, G. Stock, P. Stetson, S. Dastmalchi, and U. Schmidt-Erfurth, “Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography,” Br J Ophthalmol 92, 197–203 (2008).
[Crossref]

Clin Experiment Ophthalmol. (1)

P Sen, A Bhargava, L Vijaya, and R George, “Prevalence of idiopathic macular hole in adult rural and urban south Indian population,” Clin Experiment Ophthalmol. 36, 257–260 (2008).
[Crossref] [PubMed]

Graefes Arch Clin Exp Ophthalmol (1)

J. Michalewski, Z. Michalewska, S. Cisiecki, and J. Nawrocki, “Morphologically functional correlations of macular pathology connected with epiretinal membrane formation in spectral optical coherence tomography (SOCT),” Graefes Arch Clin Exp Ophthalmol 245, 1623–1631 (2007).
[Crossref] [PubMed]

Invest Ophthalmol Vis Sci (4)

V. J. Srinivasan, T. H. Ko, M. Wojtkowski, M. Carvalho, A. Clermont, S. E. Bursell, Q. H. Song, J. Lem, J. S. Duker, J. S. Schuman, and J. G. Fujimoto, “Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography,” Invest Ophthalmol Vis Sci 47, 5522–5528 (2006).
[Crossref] [PubMed]

M. L. Gabriele, H. Ishikawa, G. Wollstein, R. A. Bilonick, L. Kagemann, M. Wojtkowski, V. J. Srinivasan, J. G. Fujimoto, J. S. Duker, and J. S. Schuman, “Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning,” Invest Ophthalmol Vis Sci 48, 3154–3160 (2007).
[Crossref] [PubMed]

P. J. Patel, F. K. Chen, F. Ikeji, W. Xing, C. Bunce, L. Da Cruz, and A. Tufail, “Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration,” Invest Ophthalmol Vis Sci 49, 1084–1088 (2008).
[Crossref] [PubMed]

U. Schmidt-Erfurth, R. A. Leitgeb, S. Michels, B. Povazay, S. Sacu, B. Hermann, C. Ahlers, H. Sattmann, C. Scholda, A. F. Fercher, and W. Drexler, “Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases,” Invest Ophthalmol Vis Sci 46, 3393–3402 (2005).
[Crossref] [PubMed]

Invest Ophthalmol Vis Sci. (3)

P. J. Patel, F. K. Chen, L. da Cruz, and A. Tufail, “Segmentation Error in Stratus Optical Coherence Tomography for Neovascular Age-related Macular Degeneration,” Invest Ophthalmol Vis Sci. 50, 399–404 (2008).
[Crossref] [PubMed]

UE Wolf-Schnurrbusch, V Enzmann, CK Brinkmann, and S Wolf “Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination” Invest Ophthalmol Vis Sci. 49, 3095–3099 (2008). Epub 2008 Mar 31.
[Crossref] [PubMed]

M Fleckenstein, P Charbel Issa, HM Helb, S Schmitz-Valckenberg, RP Finger, HP Scholl, KU Loeffler, and FG Holz. “High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration” Invest Ophthalmol Vis Sci. 49, 4137–4144 (2008). Epub 2008 May 16.
[Crossref] [PubMed]

J Biomed Opt (1)

G. M. Somfai, H. M. Salinas, C. A. Puliafito, and D. C. Fernandez, “Evaluation of potential image acquisition pitfalls during optical coherence tomography and their influence on retinal image segmentation,” J Biomed Opt 12, 041209 (2007).
[Crossref] [PubMed]

N Engl J Med (2)

D. M. Brown, P. K. Kaiser, M. Michels, G. Soubrane, J. S. Heier, R. Y. Kim, J. P. Sy, and S. Schneider, “Ranibizumab versus verteporfin for neovascular age-related macular degeneration,” N Engl J Med 355, 1432–1444 (2006).
[Crossref] [PubMed]

P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, and R. Y. Kim, “Ranibizumab for neovascular age-related macular degeneration,” N Engl J Med 355, 1419–1431 (2006).
[Crossref] [PubMed]

Nat Med (1)

N. Ferrara, H. P. Gerber, and J. LeCouter, “The biology of VEGF and its receptors,” Nat Med 9, 669–676 (2003).
[Crossref] [PubMed]

Ophthalmology (7)

C. A. Puliafito, M. R. Hee, C. P. Lin, E. Reichel, J. S. Schuman, J. S. Duker, J. A. Izatt, E. A. Swanson, and J. G. Fujimoto, “Imaging of macular diseases with optical coherence tomography,” Ophthalmology 102, 217–229 (1995).
[PubMed]

S. R. Sadda, Z. Wu, A. C. Walsh, L. Richine, J. Dougall, R. Cortez, and L. D. LaBree, “Errors in retinal thickness measurements obtained by optical coherence tomography,” Ophthalmology 113, 285–293 (2006).
[Crossref] [PubMed]

T. H. Ko, J. G. Fujimoto, J. S. Schuman, L. A. Paunescu, A. M. Kowalevicz, I. Hartl, W. Drexler, G. Wollstein, H. Ishikawa, and J. S. Duker, “Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology,” Ophthalmology 112, 1922 e1921–1915 (2005).
[Crossref]

Y. Ojima, M. Hangai, M. Sasahara, N. Gotoh, R. Inoue, Y. Yasuno, S. Makita, T. Yatagai, A. Tsujikawa, and N. Yoshimura, “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology 114, 2197–2207 (2007).
[Crossref] [PubMed]

V. J. Srinivasan, M. Wojtkowski, A. J. Witkin, J. S. Duker, T. H. Ko, M. Carvalho, J. S. Schuman, A. Kowalczyk, and J. G. Fujimoto, “High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 113, 2054 e2051–2014 (2006).
[Crossref]

M. Wojtkowski, V. Srinivasan, J. G. Fujimoto, T. Ko, J. S. Schuman, A. Kowalczyk, and J. S. Duker, “Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography,” Ophthalmology 112, 1734–1746 (2005).
[Crossref] [PubMed]

C. Ahlers, I. Golbaz, G. Stock, A. Fous, S. Kolar, C. Pruente, and U. Schmidt-Erfurth, “Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration,” Ophthalmology 115, e39–46 (2008).
[Crossref] [PubMed]

Prog Retin Eye Res (3)

M. E. van Velthoven, D. J. Faber, F. D. Verbraak, T. G. van Leeuwen, and M. D. de Smet, “Recent developments in optical coherence tomography for imaging the retina,” Prog Retin Eye Res 26, 57–77 (2007).
[Crossref]

W. Drexler and J. G. Fujimoto, “State-of-the-art retinal optical coherence tomography,” Prog Retin Eye Res 27, 45–88 (2008).
[Crossref]

U. M. Schmidt-Erfurth and C. Pruente, “Management of neovascular age-related macular degeneration,” Prog Retin Eye Res 26, 437–451 (2007).
[Crossref] [PubMed]

Science (1)

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, and C. A. Puliafito, and et al., “Optical coherence tomography,” Science 254, 1178–1181 (1991).
[Crossref] [PubMed]

Other (1)

“Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group,” Ophthalmology98, 807–822 (1991).
[PubMed]

Cited By

OSA participates in Crossref's Cited-By Linking service. Citing articles from OSA journals and other participating publishers are listed here.

Alert me when this article is cited.


Figures (4)

Fig. 1.
Fig. 1.

Macular Pucker. The configuration of retinal traction and folds can be visualized in 2d and 3d images. The retinal pigment epithelium (RPE) and the external limiting membrane (ELM) are of regular shape. 3D data is available in View 1.

Fig. 2.
Fig. 2.

Macular hole. Details are visualized in View 2. Figure 2a shows the 3D-image, whereas 2b shows the symmetric arrangement of cysts around the macular hole. 3c nicely shows the operculum attached to the vitreus and the central gap in the intraretinal structure. High resolution of SD-OCT imaging allows visualizing discrete features like the external limiting membrane (ELM).

Fig. 3.
Fig. 3.

This figure shows a large detachment of the retinal pigment epithelium (PED). The basis of this PED is of irregular shape (View 3). Zones of significant pigment epithelial atrophy can be observed in View 4.

Fig. 4.
Fig. 4.

This figure demonstrates the typical intraretinal changes in neovascular age-related macular degeneration (nAMD). Subretinal fluid (SRF) has been proven to be a relevant marker for prognosis of nAMD disease and can be observed in distinct locations. 3D-data is available in View 5.

Datasets

Datasets associated with ISP articles are stored in an online database called MIDAS. Clicking a "View" link in an OSA ISP article will launch the ISP software (if installed) and pull the relevant data from MIDAS. Visit MIDAS to browse and download the datasets directly. A package containing the PDF article and full datasets is available in MIDAS for offline viewing.

Questions or Problems? See the ISP FAQ. Already used the ISP software? Take a quick survey to tell us what you think.

Metrics